Luong Tien Phat
Luong Tien Phat has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Duong Thanh Tai
Department of Medical Physics Faculty of Medicine Nguyen Tat Thanh University Ho Chi Minh City Vietnam
4 shared publications - James Chun Lam Chow
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1X6, Canada
4 shared publications - Peter Sandwall
Ohio Health, Mansfield, OH
3 shared publications - Abdelmoneim Sulieman
Department of Radiological Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, P.O. Box 6664, Al Ahsa 31982, Saudi Arabia
2 shared publications - David Andrew Bradley
Centre for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Petaling Jaya 47500, Selangor, Malaysia
2 shared publications - Mai Thi Thao
Department of Artificial Intelligence Convergence, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Korea
2 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (12) , e70414
From standard to stratified: Modeling NTCP and EAR to personalize daily MV‐CBCT in radiotherapy
Purpose: To evaluate the cumulative radiobiological impact of daily megavoltage cone‐beam computed tomography (MV‐CBCT) imaging dose based on normal tissue complication probability (NTCP) and excess absolute risk (EAR) of secondary malignancies among radiotherapy patients treated for breast, pelvic, and head & neck cancers. This study investigated whether MV‐CBCT imaging dose warrants protocol personalization according to patient age, anatomical treatment site, and organ‐specific radiosensitivity. Methods: This retrospective study included cohorts of breast ( n = 30), pelvic ( n = 17), and head & neck ( n = 20) cancer patients undergoing radiotherapy with daily MV‐CBCT. Imaging dose distributions employing two common MV‐CBCT protocols (5 and 10 MU per fraction) were analyzed. NTCP values were estimated using logistic models, while EAR were calculated using Schneider's organ equivalent dose (OED)‐based model, integrating organ‐specific dose, patient age, and established tissue‐specific risk coefficients. Comparative statistical analyses were conducted using paired t ‐tests, and results were further stratified by patient age (< 40, 40–60, > 60 years). Results: In breast cancer patients, NTCP values increased significantly for lung tissue when comparing the 10 MU protocol to the 5 MU one ( p < 0.001), while those for heart and breast tissues showed minimal and insignificant differences. EAR estimations revealed substantial risk increases among younger breast cancer patients (< 40 years), with some exceeding 15 cases per 10 000 person‐years under the 10 MU protocol. Conversely, pelvic and head & neck cohorts demonstrated consistently low NTCP and EAR values (< 1%), with no meaningful differences observed between the two imaging protocols. Across all cancer sites, younger age consistently correlated with higher secondary cancer risks. Conclusion: Routine daily MV‐CBCT imaging at the 10 MU protocol possesses minimal additional risk in pelvic and head & neck radiotherapy. However, among breast cancer patients, particularly those under 40 years, the 10 MU protocol significantly elevates the theoretical secondary cancer risk estimates and lung NTCP. These findings support transitioning from conventional uniform imaging approach toward personalized MV‐CBCT protocols, tailored according to patient age, anatomical site, and organ radiosensitivity. A stratified imaging framework is proposed to optimize clinical outcomes, balancing treatment accuracy, and long‐term patient safety.
- 10 December 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (12) , e70414
Open AccessFrom standard to stratified: Modeling NTCP and EAR to personalize daily MV‐CBCT in radiotherapy
Purpose: To evaluate the cumulative radiobiological impact of daily megavoltage cone‐beam computed tomography (MV‐CBCT) imaging dose based on normal tissue complication probability (NTCP) and excess absolute risk (EAR) of secondary malignancies among radiotherapy patients treated for breast, pelvic, and head & neck cancers. This study investigated whether MV‐CBCT imaging dose warrants protocol personalization according to patient age, anatomical treatment site, and organ‐specific radiosensitivity. Methods: This retrospective study included cohorts of breast ( n = 30), pelvic ( n = 17), and head & neck ( n = 20) cancer patients undergoing radiotherapy with daily MV‐CBCT. Imaging dose distributions employing two common MV‐CBCT protocols (5 and 10 MU per fraction) were analyzed. NTCP values were estimated using logistic models, while EAR were calculated using Schneider's organ equivalent dose (OED)‐based model, integrating organ‐specific dose, patient age, and established tissue‐specific risk coefficients. Comparative statistical analyses were conducted using paired t ‐tests, and results were further stratified by patient age (< 40, 40–60, > 60 years). Results: In breast cancer patients, NTCP values increased significantly for lung tissue when comparing the 10 MU protocol to the 5 MU one ( p < 0.001), while those for heart and breast tissues showed minimal and insignificant differences. EAR estimations revealed substantial risk increases among younger breast cancer patients (< 40 years), with some exceeding 15 cases per 10 000 person‐years under the 10 MU protocol. Conversely, pelvic and head & neck cohorts demonstrated consistently low NTCP and EAR values (< 1%), with no meaningful differences observed between the two imaging protocols. Across all cancer sites, younger age consistently correlated with higher secondary cancer risks. Conclusion: Routine daily MV‐CBCT imaging at the 10 MU protocol possesses minimal additional risk in pelvic and head & neck radiotherapy. However, among breast cancer patients, particularly those under 40 years, the 10 MU protocol significantly elevates the theoretical secondary cancer risk estimates and lung NTCP. These findings support transitioning from conventional uniform imaging approach toward personalized MV‐CBCT protocols, tailored according to patient age, anatomical site, and organ radiosensitivity. A stratified imaging framework is proposed to optimize clinical outcomes, balancing treatment accuracy, and long‐term patient safety.
- Open Access
- 23 April 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (8) , 925-932
Enhancing patient positioning accuracy: evaluating daily cone beam computed tomography in the halcyon system
Background: Precise patient positioning is crucial for successful radiotherapy, ensuring accurate delivery of radiation to tumors while minimizing exposure to healthy tissues. Positional errors can significantly impact treatment efficacy and increase side effects. This study evaluates the effectiveness of daily cone beam computed tomography (CBCT) imaging in the Halcyon system for detecting and correcting patient misalignments across various cancer types and treatment sites. Methods: A retrospective analysis was conducted on 411 patients treated with the Varian Halcyon linear accelerator from August 2022 to August 2024. Patients were grouped based on tumor location: Head and Neck (118 patients), Chest (188 patients), and Pelvis (105 patients). Daily pre-treatment CBCT scans were performed to verify positioning, with shifts in the x, y, and z axes quantified and adjusted using automated couch corrections. Results: The study revealed average positional shifts along the x-axis of ~0.112 cm, while both the Chest and Pelvic groups recorded 0.194 cm. The y-axis deviations were 0.135 cm for Head and Neck, 0.206 cm for Chest, and 0.195 cm for the Pelvis. On the z-axis, a mean deviation of 0.07 cm was found for the Head and Neck group, while 0.11 cm for the Chest group, and 0.085 cm for the Pelvic group. The Head and Neck group exhibited the smallest standard deviations across all axes, indicating greater positional consistency. Normalized density distributions showed distinct emergent patterns, the Head and Neck group showing tighter distributions compared to the broader distributions observed in the Chest and Pelvic groups. Conclusions: Daily CBCT imaging in the Halcyon system significantly enhances patient positioning accuracy in radiotherapy. The findings demonstrate that this approach minimizes positional shifts, particularly in the Head and Neck region, essential for optimizing treatment outcomes and reducing the risk of adverse effects. Future studies should further explore the integration of advanced imaging techniques to improve precision in patient positioning.
- 23 April 2025
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 55 (8) , 925-932
Open AccessEnhancing patient positioning accuracy: evaluating daily cone beam computed tomography in the halcyon system
Background: Precise patient positioning is crucial for successful radiotherapy, ensuring accurate delivery of radiation to tumors while minimizing exposure to healthy tissues. Positional errors can significantly impact treatment efficacy and increase side effects. This study evaluates the effectiveness of daily cone beam computed tomography (CBCT) imaging in the Halcyon system for detecting and correcting patient misalignments across various cancer types and treatment sites. Methods: A retrospective analysis was conducted on 411 patients treated with the Varian Halcyon linear accelerator from August 2022 to August 2024. Patients were grouped based on tumor location: Head and Neck (118 patients), Chest (188 patients), and Pelvis (105 patients). Daily pre-treatment CBCT scans were performed to verify positioning, with shifts in the x, y, and z axes quantified and adjusted using automated couch corrections. Results: The study revealed average positional shifts along the x-axis of ~0.112 cm, while both the Chest and Pelvic groups recorded 0.194 cm. The y-axis deviations were 0.135 cm for Head and Neck, 0.206 cm for Chest, and 0.195 cm for the Pelvis. On the z-axis, a mean deviation of 0.07 cm was found for the Head and Neck group, while 0.11 cm for the Chest group, and 0.085 cm for the Pelvic group. The Head and Neck group exhibited the smallest standard deviations across all axes, indicating greater positional consistency. Normalized density distributions showed distinct emergent patterns, the Head and Neck group showing tighter distributions compared to the broader distributions observed in the Chest and Pelvic groups. Conclusions: Daily CBCT imaging in the Halcyon system significantly enhances patient positioning accuracy in radiotherapy. The findings demonstrate that this approach minimizes positional shifts, particularly in the Head and Neck region, essential for optimizing treatment outcomes and reducing the risk of adverse effects. Future studies should further explore the integration of advanced imaging techniques to improve precision in patient positioning.
- 17 April 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 236
Dosimetric validation of Elekta Synergy 6 MV and 10 MV photon beam models in the Monaco
- 17 April 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 236
Dosimetric validation of Elekta Synergy 6 MV and 10 MV photon beam models in the Monaco
- Open Access
- 27 March 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 236
Dosimetric analysis of beam number variations in IMRT for head-and-neck, breast, and pelvic cancers using Halcyon
- 27 March 2025
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 236
Open AccessDosimetric analysis of beam number variations in IMRT for head-and-neck, breast, and pelvic cancers using Halcyon